This funding opportunity supports research focused on discovering and developing interventions to prevent and treat substance use disorders and overdose. It includes preclinical and clinical studies, aiming to produce high-impact results that advance candidate interventions toward regulatory approval or clinical adoption. Eligible research includes medications and medical devices addressing co-morbid substance use disorders.
Eligible applicants include state, city, county, and special district governments; Native American tribal organizations and governments; nonprofits with or without 501(c)(3) status; small businesses; public housing authorities; and institutions of higher education, both public and private.
